What is the likelihood of Staphylococcus (Staph) epidermidis causing endocarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Likelihood of Staphylococcus epidermidis Causing Endocarditis

Staphylococcus epidermidis is a predominant causative organism in prosthetic valve endocarditis (PVE), particularly in early PVE occurring within the first 2 months after valve surgery, but is a relatively uncommon cause of native valve endocarditis (approximately 5% of cases). 1

Incidence and Risk Factors

  • S. epidermidis is the most common organism in early prosthetic valve endocarditis (within 2 months after surgery) 1
  • In late prosthetic valve endocarditis (>1 year after surgery), the likelihood of S. epidermidis decreases significantly, with streptococci and S. aureus becoming more common 1, 2
  • In native valve endocarditis, S. epidermidis accounts for only about 5% of cases, typically affecting patients with pre-existing valvular heart disease, particularly mitral valve prolapse 1, 3
  • Healthcare-associated procedures involving intravascular devices significantly increase the risk of S. epidermidis endocarditis 1

Clinical Presentation and Course

  • Native valve endocarditis caused by S. epidermidis typically follows an indolent course with a satisfactory response to medical or surgical therapy 1
  • Prosthetic valve endocarditis caused by S. epidermidis often presents with:
    • Fever
    • New or changing heart murmurs
    • Valve ring and myocardial abscesses (particularly with mechanical valves)
    • Potential valve dehiscence and valvular incompetence 4

Antimicrobial Susceptibility

  • S. epidermidis isolates from prosthetic valve endocarditis are frequently resistant to multiple antibiotics, including methicillin (87% of cases within 1 year of surgery) 2, 5
  • Native valve S. epidermidis isolates are generally more susceptible to antibiotics than prosthetic valve isolates 3
  • Vancomycin plus rifampin or an aminoglycoside is the recommended treatment for methicillin-resistant S. epidermidis prosthetic valve endocarditis 2

Mortality and Outcomes

  • The mortality rate for prosthetic valve endocarditis caused by S. epidermidis is high (70-80%) when treated with antibiotics alone 3
  • Surgical intervention significantly improves outcomes in complicated prosthetic valve endocarditis caused by S. epidermidis 2
  • Native valve endocarditis caused by S. epidermidis has a considerably lower mortality rate compared to prosthetic valve infections 3

Special Considerations

  • S. epidermidis should be distinguished from S. lugdunensis (another coagulase-negative staphylococcus), which causes a more virulent form of endocarditis with higher rates of perivalvular extension and metastatic infection 1
  • Other coagulase-negative staphylococci like S. capitis can rarely cause prosthetic valve endocarditis with complications such as aortic root abscess 6
  • Blood cultures may need to be incubated for longer periods to detect S. epidermidis in some cases of culture-negative endocarditis 1

Diagnostic Approach

  • The modified Duke criteria should be used for diagnosis, with S. epidermidis blood cultures considered a major criterion only when multiple positive cultures are obtained (to distinguish from contamination) 1
  • Transesophageal echocardiography is particularly important for detecting vegetations and complications in suspected prosthetic valve endocarditis 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.